Dr Reddy

Rediff.com » News » Dr Reddy

News for Dr Reddy

News
Business
Sports

Dr Reddy's Laboratories loses Rs 2.16 cr in cyber fraud

The Bengaluru police have launched a probe into a cyber fraud case where hackers allegedly infiltrated the official email communication between Bengaluru-based Group Pharmaceuticals and Dr Reddy's......

Mandaviya meets Dr Reddy's Lab chief on Sputnik V production

Union Health Minister Mansukh Mandaviya on Thursday said he has held a meeting with Dr Reddy's Laboratories Chairman Satish Reddy regarding the production and supply of COVID-19 vaccine Sputnik V.......

Dr Reddy's launches Covid drug 2-DG at Rs 990 per sachet

Drug major Dr Reddy's Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet. IMAGE:......

Delhi asks Dr Reddy's for 67L doses of Sputnik V vaccine

Amid vaccine shortage faced by Delhi, Chief Minister Arvind Kejriwal on Saturday said his government has written to Dr Reddy's Laboratories for supply of around 67 lakh doses of Russian COVID-19......

Made in India Sputnik V to be available during Sept-Oct: Dr Reddy's

Dr Reddy's Laboratories Ltd expects the locally manufactured Russia's COVID-19 vaccine Sputnik V to be available from September-October period, a senior official of the city-based drug maker said......

Non-US uptick seen driving gains for Dr Reddy's Labs

Motilal Oswal Research said Dr Reddy’s Labs delivered a better than expected Q3FY26, with strong execution in India, Europe and Russia, and favourable currency movement more than offsetting the......

Dr Reddy's profit down 14% on low Lenalidomide US sales

In the October to December period of FY26, DRL recorded a 12 per cent Y-o-Y drop in revenue from North America to Rs 2,964 crore from Rs 3,383 crore due to continued price erosion in Lenalidomide.......

Margin pressures, growth triggers to weigh on Dr Reddy's

Pharma major Dr Reddy’s Laboratories delivered a muted operational performance in the fourth quarter of financial year 2024-25 (Q4FY25), even as revenue growth remained healthy. IMAGE: Satish......

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy’s Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company’s Q3 performance and......

Domestic sales a booster dose for pharma revenues

Buoyant domestic sales are expected to lift revenues for pharma companies by 8–11 per cent in Q3FY26, even as declining generic Revlimid (cancer drug) sales in the US remain a key drag.......

Shafali blasts 34-ball 69 as India rout Sri Lanka in 2nd T20I

IMAGE: Shafali Verma celebrates her half-century during the second T20I against Sri Lanka at Dr YS Rajasekhara Reddy ACA-VDCA Cricket Stadium, in Visakhapatnam, on Tuesday. Photograph: BCCI......

Celebrating India's World Champions!

IMAGE: Nita Ambani with World Cup-winning captains Harmanpreet Kaur, Deepika T C and Rohit Sharma at the United In Triumph event in Mumbai, January 5, 2025. Photograph: Panna Bandekar India's......